← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Azacitidine currently has availability issues reported in 5 European registers: Spain, Greece, Ireland, Italy, Sweden.
Shortage ATC L01BC07 · also listed as: AZACITIDINA · AZACITIDINE · azacitidin · data refreshed 10 September 2026
As of 10 September 2026, 5 of the 9 tracked registers list current availability issues for Azacitidine, covering 8 affected product presentations. The longest-running open report was filed in Italy on 2025-01-03 and has now been open for about 20 months. Where agencies state a cause, manufacturing problems lead with 1 of the 2 stated-cause reports, followed by commercial decisions or discontinuation with 1. The furthest expected-resolution date currently on file is 2026-12-15; the earliest is 2026-09-17. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 3 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Italy reported first (2025-01-03), with Sweden following roughly 18 months later — a pattern typical of supply problems cascading between national markets. Registers in Spain, Greece, Ireland, Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Azacitidine is coded L01BC07 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇪🇸 Spain | Shortage AZACITIDINA EUGIA 25 MG/ML POLVO PARA SUSPENSION INYECTABLE EFG, 1 vial + 1 more productsAZACITIDINA SANDOZ 25 MG/ML POLVO PARA SOLUCION INYECTABLE EFG , 1 vial | 2025-01-30 | 2026-11-29 | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇬🇷 Greece | Limited availability VIDAZA PD.INJ.SUS 25MG/ML BTx1 VIAL x 100MG | 2026-06-01 | 2026-07-15 | Αυξημένη ζήτηση περιεκτικότητας JAVLOR C/S.SOL.IN 25MG/ML BTX1VIAL (ΜΕ Alternatives: Προβλήματα στην παραγωγική | register ↗ |
| 🇮🇪 Ireland | Shortage Azacitidine Accord 25 mg / mL powder for suspension for injection EU/1/1 | 2026-02-04 | — | Manufacturing delay (n/a) Alternatives: Alternative(s) available — see the national register. | register ↗ |
| 🇮🇹 Italy | Shortage AZACITIDINA ACCORD + 1 more productsAZACITIDINA AUROBINDO | 2025-01-03 | — | Cessata commercializzazione temporanea Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
| 🇸🇪 Sweden | Shortage Azacitidine Accord 25 mg/ml Pulver till injektionsvätska, suspension + 1 more productsAzacitidine Mylan 25 mg/ml Pulver till injektionsvätska, suspension | 2026-07-01 | 2026-12-15 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Azacitidine in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | AZACITIDINA ACCORD | Shortage | 2026-12-31 | — | Cessata commercializzazione temporanea |
| 🇸🇪 SE | Azacitidine Mylan 25 mg/ml Pulver till injektionsvätska, suspension | Shortage | 2026-07-21 | 2026-12-15 | |
| 🇸🇪 SE | Azacitidine Accord 25 mg/ml Pulver till injektionsvätska, suspension | Shortage | 2026-07-01 | 2026-07-31 | |
| 🇬🇷 GR | VIDAZA PD.INJ.SUS 25MG/ML BTx1 VIAL x 100MG | Limited availability | 2026-06-01 | 2026-07-15 | Αυξημένη ζήτηση περιεκτικότητας JAVLOR C/S.SOL.IN 25MG/ML BT |
| 🇪🇸 ES | AZACITIDINA SANDOZ 25 MG/ML POLVO PARA SOLUCION INYECTABLE EFG , 1 via | Shortage | 2026-03-17 | 2026-09-17 | Existen otros medicamentos con el mismo principio activo y m |
| 🇮🇪 IE | Azacitidine Accord 25 mg / mL powder for suspension for injection EU/1 | Shortage | 2026-02-04 | — | Manufacturing delay (n/a) |
| 🇪🇸 ES | AZACITIDINA EUGIA 25 MG/ML POLVO PARA SUSPENSION INYECTABLE EFG, 1 via | Shortage | 2025-01-30 | 2026-11-29 | Existen otros medicamentos con el mismo principio activo y m |
| 🇮🇹 IT | AZACITIDINA AUROBINDO | Shortage | 2025-01-03 | — | Problemi regolatori |
Yes. As of 10 September 2026, availability issues are reported in: Spain, Greece, Ireland, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-17 to 2026-12-15. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
8 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Azacitidine: AEMPS CIMA (Spain), EOF limited-availability list (Greece), HPRA (Ireland), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Azacitidine — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/azacitidine/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Azacitidine availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/azacitidine/">Azacitidine shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>